NCT03421691

A Single-Center Open-Label Study of 1064 nm for Nonablative Skin Rejuvenation

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: Cutera Inc. · Industry
• Sex: All
• Age: 35 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this investigation is to evaluate the safety and efficacy of the Cutera excel V Laser Genesis procedure utilizing the 1064nm laser for skin rejuvenation.

Detailed description

This is a single-center prospective, open-label uncontrolled study in 15 male or female subjects, age 35 to 55 years who desire non-ablative laser treatment for facial photo-rejuvenation, specifically improvement of rhytides, lentigines, erythema, telangiectasia and skin texture. Subjects will receive laser treatments and complete a follow up visit 12 weeks post-final treatment.

Conditions

• Skin Pigment
• Photoaging

Interventions

Type	Name	Description
DEVICE	excel V Laser	excel V Laser Genesis procedure utilizing 1064 nm laser

Timeline

• Start date: 2016-03-15
• Primary completion: 2018-02-07
• Completion: 2018-02-07
• First posted: 2018-02-05
• Last updated: 2023-09-06
• Results posted: 2023-09-06

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study